Keywords: Shire, Premacure, M&A, Retinopathy in prematurity, Neonatology

Shire acquires Premacure to expand in new therapy area

Article | 13 March 2013

Print This

In a second acquisition so far this year, Ireland-headquartered drugmaker Shire (LSE: SHP) said on Tuesday (March 12) that it has ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in